# Efficacy and Safety Study: Repetitive Transcranial Magnetic Stimulation (rTMS) for Treating Movement Disorders in Patients With Intracranial Hemorrhage (ICH).

Study · id `cardio:ct-nct05920473` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05920473](<https://clinicaltrials.gov/study/NCT05920473>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05920473

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 130 participants.

## Technical summary

Registry record NCT05920473. Randomized; triple masking; primary purpose treatment. Start 2023-07-01 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 130 participants (planned count; ClinicalTrials.gov record NCT05920473, source copy `cardio:ctgov-nct05920473-2023-06-27`, retrieved 2026-10-31)
- Planned start: 2023-07-01 (anticipated) (ClinicalTrials.gov record NCT05920473, source copy `cardio:ctgov-nct05920473-2023-06-27`, retrieved 2026-10-31)
- Primary completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT05920473, source copy `cardio:ctgov-nct05920473-2023-06-27`, retrieved 2026-10-31)
- Completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT05920473, source copy `cardio:ctgov-nct05920473-2023-06-27`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT05920473, source copy `cardio:ctgov-nct05920473-2023-06-27`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05920473-2023-06-27`, retrieved 2026-10-31)

## The registry's words

- Brief title: Efficacy and Safety Study: Repetitive Transcranial Magnetic Stimulation (rTMS) for Treating Movement Disorders in Patients With Intracranial Hemorrhage (ICH).
- Condition: Intracerebral Hemorrhage
- Intervention (Device): rTMS with Magstim Rapid 2 magnetic stimulation device
- Intervention (Device): sham control with Magstim Rapid 2 magnetic stimulation device
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER
- Collaborator: Rehabilitation Hospital Affiliated to National Research Center for Rehabilitation Technical Aids
- Collaborator class: UNKNOWN
- Collaborator: Shenzhen Nanshan District Shekou People's Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

## Provenance

Content hash: de9aa075bf4743fb7475ea4fd4c9fafb3e3a2063280099fb847272c0d7b931d7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
